Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLK1 | P53350 | 6/20 | 0.66 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | CNR2 | P34972 | 4/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | KDM6B | O15054 | 1/20 | 0.56 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.56 |
| ▸ | PLK3 | Q9H4B4 | 3/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.54 |
| ▸ | CNR1 | P21554 | 1/20 | 0.52 |
| ▸ | NAAA | Q02083 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30012239 | 1.00 | PLK1 (0.66) | PLK1HPGDALDH1A1HSD17B10CNR2 | |
| SCHEMBL10475728 | 1.00 | PLK1 (0.66) | PLK1HPGDALDH1A1HSD17B10CNR2 | |
| SCHEMBL11437269 | 1.00 | PLK1 (0.66) | PLK1HPGDALDH1A1HSD17B10CNR2 | |
| SCHEMBL11483067 | 1.00 | PLK1 (0.66) | PLK1HPGDALDH1A1HSD17B10CNR2 | |
| SCHEMBL5694119 | 1.00 | PLK1 (0.66) | PLK1HPGDALDH1A1HSD17B10CNR2 | |
| SCHEMBL11443814 | 1.00 | PLK1 (0.66) | PLK1HPGDALDH1A1HSD17B10CNR2 | |
| SCHEMBL11430175 | 1.00 | PLK1 (0.66) | PLK1HPGDALDH1A1HSD17B10CNR2 | |
| SCHEMBL11432358 | 1.00 | PLK1 (0.66) | PLK1HPGDALDH1A1HSD17B10CNR2 | |
| SCHEMBL5272720 | 1.00 | PLK1 (0.66) | PLK1HPGDALDH1A1HSD17B10CNR2 | |
| SCHEMBL27153029 | 1.00 | PLK1 (0.66) | PLK1HPGDALDH1A1HSD17B10CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110313158-A1 | Two Component Recyclable Heterogeneous Catalyst, Process for Preparation Thereof and its Use for Preparation of Amines | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2011-12-22 | — | — | US | claimed |
| WO-2010097815-A2 | A TWO COMPONENT RECYCLABLE HETEROGENEOUS CATALYST, PROCESS FOR PREPARATION THEREOF AND ITS USE FOR PREPARATION OF AMINES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-09-02 | — | — | WO | claimed |
| CN-110437162-B | Compound containing cyclohydroximic acid and preparation method and application thereof | 贵州医科大学 | 2021-01-05 | — | — | CN | disclosed |
| CN-110437162-A | A kind of compound of the hydroximic acid containing ring and its preparation method and application | UNIV GUIZHOU MEDICAL | 2019-11-12 | — | — | CN | disclosed |
| US-20110313158-A1 | Two Component Recyclable Heterogeneous Catalyst, Process for Preparation Thereof and its Use for Preparation of Amines | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2011-12-22 | — | — | US | disclosed |
| WO-2010097815-A2 | A TWO COMPONENT RECYCLABLE HETEROGENEOUS CATALYST, PROCESS FOR PREPARATION THEREOF AND ITS USE FOR PREPARATION OF AMINES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-09-02 | — | — | WO | disclosed |
| EP-0815871-B1 | Tape plaster comprising anthranilic acid derivatives as percutaneous absorption promotors | LINTEC CORP (JP) | 2002-07-17 | — | — | EP | disclosed |
| US-RE36138-E | AMINO ACID DERIVATIVE; DRUG DELIVERY | LINTEC CORPORATION (JP) | 1999-03-09 | — | — | US | disclosed |
| EP-0815871-A1 | A percutaneous absorption, a tape plaster and a method of promoting percutaneous absorption | LINTEC Corporation (JP) | 1998-01-07 | — | — | EP | disclosed |
| US-5413794-A | Drug delivery | LINTEC CORPORATION (JP) | 1995-05-09 | — | — | US | disclosed |
| EP-0552405-A1 | A percutaneous absorption promoter, a tape plaster and a method of promoting percutaneous absorption | LINTEC Corporation (JP) | 1993-07-28 | — | — | EP | disclosed |
| US-4212674-A | N-OLEYL-1,3-PROPANEDIAMMONIUM DIOLEATE AND/OR DERIVATIVES AND A PARTICULATE CARRIER | PLUSS-STAUFER AG (CH) | 1980-07-15 | — | — | US | disclosed |
| US-4021470-A | LUBRICANT STABILIZERS | MOBIL OIL CORPORATION (US) | 1977-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313158-A1 | Two Component Recyclable Heterogeneous Catalyst, Process for Preparation Thereof and its Use for Preparation of Amines | HCN2, RAC2, HCN1 | PLK1 2827/4885HPGD 2141/4885ALDH1A1 1225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.